Natriuretic peptides in heart failure

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10188936" target="_blank" >RIV/00216208:11110/13:10188936 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/13:10188936

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.crvasa.2013.03.010" target="_blank" >http://dx.doi.org/10.1016/j.crvasa.2013.03.010</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2013.03.010" target="_blank" >10.1016/j.crvasa.2013.03.010</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Natriuretic peptides in heart failure

Popis výsledku v původním jazyce

The worldwide incidence of heart failure is steadily increasing over the past several decades, partly due to population aging and improved survival of patients with cardiovascular diseases. Therefore the importance of biochemical substances raises whichwould uncover ongoing cardiac overload, enable the treatment monitoring and make care of the patients with heart failure more effective. According to the results of many clinical trials, this task is fulfilled at most by natriuretic peptides which becomegradually a part of standard clinical practice. Both, brain natriuretic peptide and its N-terminal propeptide help to detect heart failure in patients presenting with acute dyspnea. Moreover, the natriuretic peptide levels reflect the severity of the disease and can predict future clinical outcomes in the heart failure patients. The role of natriuretic peptides as an objective target for heart failure therapy in the outpatient care was not so well established. The human recombinant brai

Název v anglickém jazyce

Natriuretic peptides in heart failure

Popis výsledku anglicky

The worldwide incidence of heart failure is steadily increasing over the past several decades, partly due to population aging and improved survival of patients with cardiovascular diseases. Therefore the importance of biochemical substances raises whichwould uncover ongoing cardiac overload, enable the treatment monitoring and make care of the patients with heart failure more effective. According to the results of many clinical trials, this task is fulfilled at most by natriuretic peptides which becomegradually a part of standard clinical practice. Both, brain natriuretic peptide and its N-terminal propeptide help to detect heart failure in patients presenting with acute dyspnea. Moreover, the natriuretic peptide levels reflect the severity of the disease and can predict future clinical outcomes in the heart failure patients. The role of natriuretic peptides as an objective target for heart failure therapy in the outpatient care was not so well established. The human recombinant brai

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

55

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

7

Strana od-do

"E370"-"E376"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—